Skip to main content
. 2013 Oct 8;8(10):e76947. doi: 10.1371/journal.pone.0076947

Figure 2. BMP7 signaling is enhanced in Bmpr2 Δtd/+ PaSMCs.

Figure 2

(A) Immunoblots of lysates of WT (Bmpr2+/+) or Bmpr2 Δtd/+ PaSMCs treated with BMP4 or BMP7 (10 ng/ml) for various times were reacted with antibodies directed against phosphorylated and total Smad1/5/8. Quantification of the ratio of phosphorylated Smad1/5/8 to total Smad1/5/8 (analysis of 3 independent experiments) demonstrated that BMP4 signaling is similar in Bmpr2 +/+ or Bmpr2 Δtd/+ PaSMCs, whereas BMP7 signaling is greater in Bmpr2 Δtd/+ PaSMCs. *P<0.05 compared to Bmpr2 +/+ PaSMC group treated with BMP7. Id1 (B) and Smad6 (C) mRNA levels were measured by qPCR in Bmpr2 +/+ or Bmpr2 Δtd/+ PaSMCs treated with BMP4 or BMP7 (10 ng/ml) for various times. Id1 and Smad6 gene expression was normalized to Gapdh and expressed as fold-change relative to control Bmpr2 +/+ PaSMC group. *P < 0.01 compared to Bmpr2 +/+ PaSMC group treated with BMP7.